估计药物基因组学在终身有效性的估计
Zhan Ye1, John Mayer1, Emili J Leary1
1Marshfield Clinic Research Institute, Marshfield, WI, United States.
Frontiers in medicine
|November 29, 2023
概括
药物基因组变异对大多数患者的药物处方有影响. 终身基因测试可以指导药物选择,改善患者的治疗结果,并推进精准医学.
科学领域:
- 基因组医学是基因组医学.
- 药物基因组学 药物基因组学
- 临床实用性的临床实用性
背景情况:
- 药物基因中的遗传变异会影响药物代谢和反应.
- 根据药物遗传学概况,终身处方药的患者比例是未知的.
研究的目的:
- 确定药物基因组学在一般患者群体的终身临床实用性.
- 评估33种药物基因中的遗传变异对药物处方的终身影响.
主要方法:
- 300名已故患者的基因组测序,这些患者有终身医疗记录.
- 用电子健康记录评估33种药物基因中的遗传变异.
- 对药物处方模式的纵向分析.
主要成果:
- 93%的患者携带了临床相关的药物基因组变异.
- 大约80%的人被处方了平均三种可能受到其变体影响的药物.
- 最佳的药物基因组测试年龄在50岁之前,受医疗保健系统稳定性的影响.
结论:
- 药基因组测试在患者一生中具有广泛的临床影响.
- 基因组医学和药物基因组学可以在一般人群中推进精准医学.
- 早期的药物基因组测试可以优化药物处方和患者护理.
相关概念视频
Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Pharmacokinetic Models: Overview
714
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
714
Pharmacokinetic Models: Comparison and Selection Criterion
74
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
74
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
157
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
157
Time Course of Drug Effect
2.1K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.1K
Factors Affecting Drug Biotransformation: Biological
154
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
154


